Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 12, 2016 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces Second Quarter 2016 Financial Results and Provides Company Update

SEATTLE, WA--(Marketwired - Aug 12, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced Second Quarter ended June 30, 2016 financial results and provided an update on recent company...
August 10, 2016 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Provide Company Update and Discuss Second Quarter Financial Results on Conference Call on Monday, August 15, 2016

SEATTLE, WA--(Marketwired - Aug 10, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will provide a Company update and discuss second quarter 2016 financial results on Monday,...
August 05, 2016 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Settles Litigation With Besins Healthcare

SEATTLE, WA--(Marketwired - Aug 5, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) and Besins Healthcare Luxembourg SARL ("Besins") have agreed, pursuant to a Termination Agreement dated August 4,...
June 07, 2016 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Initiates Additional Drug Development Program

SEATTLE, WA--(Marketwired - Jun 7, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that it has initiated a new drug development program with oral endoxifen. Endoxifen is an active...
May 27, 2016 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces $10 Million At-the-Market Common Stock Purchase Agreement With Aspire Capital Fund, LLC

SEATTLE, WA--(Marketwired - May 27, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) today announced that it has entered into a $10 million stock purchase agreement with Aspire Capital Fund, LLC. Under...
May 05, 2016 16:01 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces First Quarter 2016 Financial Results and Provides Company Update

SEATTLE, WA--(Marketwired - May 5, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced First Quarter ended March 31, 2016 financial results and provided an update on recent company...
May 03, 2016 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Host First Quarter 2016 Financial Results and Company Update Conference Call on Thursday, May 5, 2016

SEATTLE, WA--(Marketwired - May 3, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will host a conference call on Thursday May 5, 2016 at 4:30 pm eastern time to review First...
March 30, 2016 16:01 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces 2015 Financial Results and Provides Company Update

SEATTLE, WA--(Marketwired - Mar 30, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced 2015 financial results and provided an update on recent company developments. Steve...
March 25, 2016 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Host 2015 Financial Results and Company Update Conference Call on Wednesday, March 30, 2016

SEATTLE, WA--(Marketwired - Mar 25, 2016) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will host a conference call on Wednesday, March 30, 2016 at 4:30 pm eastern time to review...
March 02, 2016 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces the Opening of Its First Phase 2 Clinical Trial of Intraductal Fulvestrant Administration in Women With Ductal Carcinoma in Situ (DCIS) or Breast Cancer

SEATTLE, WA--(Marketwired - Mar 2, 2016) - Atossa Genetics Inc. (NASDAQ: ATOS), a healthcare company developing novel pharmaceutical delivery methods to address breast conditions, including cancer,...